Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Avrobio reported $-21577000 in Net Income for its fiscal quarter ending in September of 2023.

Net Income Change Date
Adcock Ingram Holdings ZAR 430.06M 38.29M Jun/2023
Alnylam Pharmaceuticals USD 147.75M 423.78M Sep/2023
Bluebird Bio USD -71731000 1.18M Sep/2023
Deva Holding AS TRY 583.98M 319.1M Sep/2023
Ecofibre AUD -22305000 4.7M Jun/2023
Gilead Sciences USD 2.18B 1.14B Sep/2023
Ionis Pharmaceuticals USD -147410000 62.12M Sep/2023
Knight Therapeutics CAD 9.59M 7.75M Sep/2023
Laboratorios Farma EUR 66.65M 52.4M Jun/2023
Malin Corporation EUR 1.1M 10.6M Jun/2023
Medical Developments International AUD -8267000 10.92M Jun/2023
Neuren Pharmaceuticals AUD 47.8M 40.57M Jun/2023
Organigram Holdings CAD -213451000 205.96M Mar/2023
Ovoca Bio EUR -5652000 3.28M Jun/2022
Pfizer USD -2382000000 4.71B Sep/2023
Pharma Mar EUR 1.52M 3.5M Sep/2023
Probiotec AUD 5.56M 96.63K Jun/2023
Qiagen NV USD 77.82M 2.97M Sep/2023
Roche Holding CHF 7.14B 3.25B Jun/2023
Sarepta Therapeutics USD -40937000 17M Sep/2023
Sartorius EUR 8.7M 86.3M Sep/2023
Sino Biopharmaceutical CNY 1.26B 636.25M Jun/2023
Takeda JPY -48030000000 137.43B Sep/2023